文献速递流行病学与生物统计医学教育与科研方法

公共试验数据库中介入性试验的数据质量评估

Data quality assessment of interventional trials in public trial databases.
PubMed 文献 · J Clin Epidemiol · 2024-09-05

本研究检索了2000至2015年间ClinicalTrials.Gov上的介入性全膝关节置换术试验,提取必填与选填信息要素,并从一致性、准确性、完整性和及时性四个维度评估注册数据的质量。共纳入816项试验,发现数据不规范率差异极大,其中61%已完成试验未报告结局,49%的试验在开始日期后超过3个月才注册。作者认为注册数据质量存在显著差异,试验申办方应确保信息可靠、一致、最新、透明且准确,数据库用户基于注册数据下结论时需保持批判性。

要点

  • 共纳入816项介入性全膝关节置换术试验,数据不规范率范围0%至100%。
  • 61%的已完成全膝关节置换术试验未报告其结局。
  • 49%的试验在开始日期后超过3个月才注册。

核心结论

  • 注册的临床全膝关节置换术试验数据质量存在显著差异。
  • 试验申办方应致力于确保其提供的信息可靠、一致、最新、透明且准确。
  • ClinicalTrials.Gov用户基于注册数据得出结论时需保持批判性。

研究设计与样本

  • 研究检索了ClinicalTrials.Gov上2000至2015年间的介入性全膝关节置换术试验。
  • 研究提取了必填与选填的试验信息要素,并采用ClinicalTrials.Gov的变量定义。
  • 研究对数据质量报告框架、清单及医疗数据库不规范情况概述进行了文献综述。
  • 研究从一致性、准确性、完整性和及时性四个属性识别并评估数据质量。
  • 共纳入816项介入性全膝关节置换术试验。

主要发现

  • 数据不规范率变化范围很大,为0%至100%。
  • 不一致性范围为0%至36%,最常见的是将非随机标记为分配与「单组」分配试验设计组合在一起。
  • 不准确性范围为0%至100%。
  • 不完整性范围为0%至61%,61%的已完成全膝关节置换术试验未报告其结局。
  • 在及时性不规范方面,49%的试验在开始日期后超过3个月才注册。

临床怎么用

  • 作者认为,试验申办方应致力于确保其提供的信息可靠、一致、最新、透明且准确。
  • 作者认为,ClinicalTrials.Gov用户基于注册数据得出结论时需保持批判性。
  • 作者认为,这种意识将增加对已发表文章和治疗方案做出明智决策,包括复制和改进试验设计。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: High-quality data entry in clinical trial databases is crucial to the usefulness, validity, and replicability of research findings, as it influences evidence-based medical practice and future research. Our aim is to assess the quality of self-reported data in trial registries and present practical and systematic methods for identifying and evaluating data quality. STUDY DESIGN AND SETTING: We searched ClinicalTrials.Gov (CTG) for interventional total knee arthroplasty (TKA) trials between 2000 and 2015. We extracted required and optional trial information elements and used the CTG's variables' definitions. We performed a literature review on data quality reporting on frameworks, checklists, and overviews of irregularities in healthcare databases. We identified and assessed data quality attributes as follows: consistency, accuracy, completeness, and timeliness. RESULTS: We included 816 interventional TKA trials. Data irregularities varied widely: 0%-100%. Inconsistency ranged from 0% to 36%, and most often nonrandomized labeled allocation was combined with a "single-group" assignment trial design. Inaccuracy ranged from 0% to 100%. Incompleteness ranged from 0% to 61%; 61% of finished TKA trials did not report their outcome. With regard to irregularities in timeliness, 49% of the trials were registered more than 3 months after the start date. CONCLUSION: We found significant variations in the data quality of registered clinical TKA trials. Trial sponsors should be committed to ensuring that the information they provide is reliable, consistent, up-to-date, transparent, and accurate. CTG's users need to be critical when drawing conclusions based on the registered data. We believe this awareness will increase well-informed decisions about published articles and treatment protocols, including replicating and improving trial designs.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Iken AR, Poolman RW, Gademan MGJ, et al. Data quality assessment of interventional trials in public trial databases. J Clin Epidemiol. 2024. PMID: 39243872. doi:10.1016/j.jclinepi.2024.111516

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。